Audited standalone and consolidated financial results & statements for the quarter and year ended 31.03.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Decipher Labs reported a standalone revenue of Rs 113.58 lakh for FY26, up 33% from Rs 85.32 lakh in FY25, though it remains loss-making with a net loss of Rs 24.68 lakh (vs Rs 34.02 lakh loss prior year). On a consolidated basis, revenue declined sharply to Rs 1405.80 lakh from Rs 2261.35 lakh (down ~38%), with a net loss of Rs 308.43 lakh but improving from Rs 500.12 lakh loss in the prior year. The company has two segments — pharma manufacturing/trading and consultancy services. The standalone balance sheet shows negative other equity of Rs 185.94 lakh, indicating accumulated losses eroding shareholder funds. Borrowings rose to Rs 50.32 lakh from Rs 2.45 lakh. The auditors issued an unmodified opinion, and no going concern emphasis was flagged despite negative equity. The consolidated cash flow from operations was deeply negative at Rs 208.32 lakh (standalone: Rs 28.85 lakh negative).
The stock shows mixed signals: standalone revenue growth is positive, but the sharp consolidated revenue decline and persistent losses, combined with negative equity and heavy operating cash outflows, raise significant concerns about the company's financial health and ability to sustain operations without fresh capital.